OBJECTIVE: To compare blood pressure control, satisfaction, and adherence to drug treatment in patients with treated hypertension followed up by their family physicians either every three months or every six months for three years. DESIGN: Randomised equivalence clinical trial. Settings 50 family practices in south eastern Ontario, Canada. PARTICIPANTS: 609 patients aged 30-74 years with essential hypertension receiving drug treatment whose hypertension had been controlled for at least three months before entry into the study. RESULTS:302 patients were randomly assigned to follow up every three months and 307 to follow up every six months. Baseline variables in the two groups were similar. As expected, patients in the six month group had significantly fewer visits, but patients in both groups visited their doctor more frequently than their assigned interval. Mean blood pressure was similar in the groups, as was control of hypertension. Patient satisfaction and adherence to treatment were similar in the groups. About 20% of patients in each group had blood pressures that were out of control during the study. CONCLUSIONS: Follow up of patients with treated essential hypertension every six months is equivalent to follow up every three months. Patient satisfaction and adherence to treatment are the same for these follow up intervals. As about 20% of patients' hypertension was out of control at any time during the study in both groups, the frequency of follow up may not the most important factor in the control of patients' hypertension by family practitioners.
RCT Entities:
OBJECTIVE: To compare blood pressure control, satisfaction, and adherence to drug treatment in patients with treated hypertension followed up by their family physicians either every three months or every six months for three years. DESIGN: Randomised equivalence clinical trial. Settings 50 family practices in south eastern Ontario, Canada. PARTICIPANTS: 609 patients aged 30-74 years with essential hypertension receiving drug treatment whose hypertension had been controlled for at least three months before entry into the study. RESULTS: 302 patients were randomly assigned to follow up every three months and 307 to follow up every six months. Baseline variables in the two groups were similar. As expected, patients in the six month group had significantly fewer visits, but patients in both groups visited their doctor more frequently than their assigned interval. Mean blood pressure was similar in the groups, as was control of hypertension. Patient satisfaction and adherence to treatment were similar in the groups. About 20% of patients in each group had blood pressures that were out of control during the study. CONCLUSIONS: Follow up of patients with treated essential hypertension every six months is equivalent to follow up every three months. Patient satisfaction and adherence to treatment are the same for these follow up intervals. As about 20% of patients' hypertension was out of control at any time during the study in both groups, the frequency of follow up may not the most important factor in the control of patients' hypertension by family practitioners.
Authors: L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell Journal: J Hum Hypertens Date: 1999-09 Impact factor: 3.012
Authors: V L Burt; J A Cutler; M Higgins; M J Horan; D Labarthe; P Whelton; C Brown; E J Roccella Journal: Hypertension Date: 1995-07 Impact factor: 10.190
Authors: Sarah L Cutrona; Niteesh K Choudhry; Michael A Fischer; Amber Servi; Joshua N Liberman; Troyen A Brennan; William H Shrank Journal: Am J Manag Care Date: 2010 Impact factor: 2.229
Authors: A Dalfó i Baqué; R Capillas Peréz; M Guarch Rocarias; M Figueras Sabater; A Ylla-Català Passola; M Balañá Vilanova; Jm Vidal Taboada; A Cobos Carbó Journal: Aten Primaria Date: 2005-03-31 Impact factor: 1.137
Authors: Marshall Godwin; Susan Streight; Elena Dyachuk; E Caroline van den Hooven; Janneke Ploemacher; Rachelle Seguin; Sharon Cuthbertson Journal: Can Fam Physician Date: 2008-01 Impact factor: 3.275
Authors: Paulien R Wermeling; Maureen van den Donk; Kees J Gorter; G Ardine de Wit; Yolanda van der Graaf; Guy Ehm Rutten Journal: BMC Fam Pract Date: 2010-05-11 Impact factor: 2.497
Authors: Joel Broomfield; Nicola Schieda; Shannon M Sullivan; Larry W Chambers; Janusz Kaczorowski; Tina Karwalajtys Journal: Can Fam Physician Date: 2008-02 Impact factor: 3.275